RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:market CRAZYNESSGenie29j wrote: Nope - but I'm also not screaming "greed".
What I am saying it's if people are claiming the Replicel team is "greedy" because they are buying at these low prices - it's a false claim bc WE ALL have access to these special share offerings and/or the open market.
The way I see it is They (the Replicel team - aka Andrew) are doing everything they can keep this company afloat - I think every shareholder should be grateful for their investments vs criticizing. They clearly feel good about things, but need cash to at minimum get through the Shiseido hearing and getting the device to market. I cannot image they are pumping more cash into this company if they weren't optimistic. They may see the pot of gold at the end of this dark forest
tgat said, I may invest on this round. I am already (very) heavily overweight in this company - so I am unsure I want to risk even more at this point, but tbd - I have bought more open market shares this past week. I would ideally like to see some positive news being released before I risk even more.
Remember Genie29j: "Greed is good". haha
Seriously though I am on your side here regarding infusing working capital into a cash strapped company through PP's. This is a pivotal year for Replicel and they need working capital to ride out the year to get the Arbitraitor's judgement mid year and the Dermal Injector to market. That is a given for all of us. No one disputes that.
The downside is these PP's stifle retail buying. The current average volume is approx. 9,500 which is not enough to move the share price. This past few years have been one PP after another. Why would anyone buy on the open market when as you say they can buy into these cheap PP's at $.10.
Enough is enough ! Let's now see some volume in the exchanges where Replicel is traded. If anyone wanting in now were to buy retail we might see some upward movement. Also in the last PP announcement there was not a closing date which is a bit odd.